Peptris Technologies


Founders

Venkatasubramanian Narayanan

Current Revenue

-

Valuation

-

Products

pepAI

Notes

Source: DeepTech Club
CSV Vertical: Health care
Funding Status: Bootstrapped
Total Funding: 0

pepAI is a machine learning platform that predicts small molecule-protein and protein-protein interactions to discover small molecule/antibody/protein-based therapies. The platform can predict interactions for millions of assays in a day with accuracy rivaling a wet lab experiment. Our therapeutic areas of focus are Oncology and Inflammation.


Metrics

Attribute Metric Reference Company Value
No metrics recorded.